What is the current price and short-term outlook for BRN.AX stock?

BRN.AX stock trades at **A$0.13** pre-market on 26 Feb 2026. Short-term outlook is cautious; technicals are oversold but volume is low. Watch the 50-day MA at **A$0.16** and the earnings release on 04 Mar 2026 for catalysts.

How does Meyka AI forecast BRN.AX stock performance?

Meyka AI's forecast model projects **A$0.15** over 12 months for BRN.AX stock, an implied upside of **16.21%** versus today. Forecasts are model-based projections and not guarantees.

What are the key financial risks for BRN.AX stock investors?

Key risks include continued negative EPS (**-A$0.02**), negative operating cash flow per share (**-A$0.00699**), high price/sales (**164.60**) and reliance on successful Akida deployments to drive revenue growth.

Are there clear adoption opportunities for BrainChip that support BRN.AX stock?

Yes. BrainChip’s Akida targets low-power edge AI markets in automotive, security and industrial sensors. Adoption and commercial wins would materially de-risk BRN.AX stock’s valuation if they convert to repeatable revenue.

AU Stocks

A$0.13 BRN.AX BrainChip (ASX) pre-market 26 Feb 2026: AI edge chip outlook

ByHuzaifa Zahoor February 26, 2026

BRN.AX stock trades at A$0.13 pre-market on 26 Feb 2026, down from its 52-week high of A$0.32 and reflecting weak short-term momentum in the AI semiconductors space. Volume sits at 4,096,378 shares versus an average of 8,098,584, showing below-average trading interest ahead of the company’s earnings announcement on 04 Mar 2026. Investors focused on AI edge chips will weigh BrainChip Holdings Ltd’s technology progress against thin revenues and persistent losses. This update frames near-term catalysts, valuation metrics, technical signals, and a model forecast to help investors in the ASX technology universe.